<DOC>
	<DOCNO>NCT01055938</DOCNO>
	<brief_summary>An open label , balance , randomize , two-treatment , two-period , two-sequence , single dose , crossover , bioequivalence study Divalproex Sodium coat particle capsule 125 mg Depakote® Sprinkle125 mg capsule healthy , adult , human subject fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Dr. Reddy 's Divalproex Sodium Capsules ( Sprinkle ) , 125 mg Under Fasting Conditions</brief_title>
	<detailed_description>An open label , balance , randomize , two-treatment , two-period , two-sequence , single dose , crossover , bioequivalence study Divalproex Sodium Capsules ( Sprinkle ) , 125 mg Dr.Reddy 's Laboratories Limited , compare Depakote® Sprinkle 125 mg capsule Abbott Laboratories , USA healthy , adult , human subject fast condition adequate washout period 10 day .</detailed_description>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Subjects must fulfill follow criterion consider inclusion study : 1 . Subjects provide write informed consent . 2 . Subjects must healthy , adult , human being within 1845 year age ( inclusive ) weigh least 50 kg . 3 . Having Body Mass Index ( BMI ) 18.5 24.9 ( inclusive ) , calculate weight Kg/height m2 4 . Subjects must normal health determine medical history physical examination perform within 21 day prior commencement study . 5 . Subjects whose screen laboratory value within normal limit consider physician/investigator clinical significance . 6 . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . The subject exclude base follow criterion screen study 1 . Subjects incapable understanding informed consent . 2 . Subjects : 1 . Systolic blood pressure le 90 mm Hg 140 mm Hg 2 . Diastolic blood pressure le 60 mm Hg 94 mm Hg . Minor deviation ( 24 mm Hg ) checkin may acceptable discretion physician/investigator . 3 . Pulse rate 50/min 100/min . 3 . History hypersensitivity idiosyncratic reaction Investigational drug product relate drug . 4 . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . 5 . Consumption grapefruit past ten day prior dose day completion study . 6 . Regular smoker habit smoke nine cigarette per day difficulty abstain smoke 48 hour dose sampling period . 7 . Subjects take counter prescribed medication enzyme modify systemic medication last 7 30 day respectively dose . 8 . Subj eets participate clinical investigation use experimental drug/donated blood past 90 day date start study . 9 . Subjects clinically significant abnormality ( Laboratory Findings , ECG , XRay , Drugs abuse , Alcohol etc. , ) and/or significant disease ( HIV , HCV , Syphilis , Hepatitis B etc. , ) . 10 . Female subject pregnant able ( woman child bear potential ) become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>